The cardiac effects of therapeutic plasma concentrations of imipramine
- 1 May 1978
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 135 (5) , 534-538
- https://doi.org/10.1176/ajp.135.5.534
Abstract
The authors studied the effects of imipramine hydrochloride at plasma concentrations associated with antidepressant activity in seven patients hospitalized for severe depressive illness. They found that the drug usually produced prolongation of intraventricular cardiac conduction. Although this was generally well tolerated, the authors suggest that patients with preexisting conduction system disease may be at increased risk when taking tricyclic antidepressants. They feel that the orthostatic hypotension seen in all seven patients represents a potentially serious problem with tricyclic antidepressants. They discuss the antiarrhythmic properties associated with imipramine and significant interactions between imipramine and drugs taken by patients with cardiovascular disease.Keywords
This publication has 12 references indexed in Scilit:
- Clinical Implications of Imipramine Plasma Levels for Depressive IllnessArchives of General Psychiatry, 1977
- Cardiac Antiarrhythmic Effect of Imipramine HydrochlorideNew England Journal of Medicine, 1977
- Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levelsPsychopharmacology, 1976
- Tricyclic antidepressant overdose: Clinical presentation and plasma levelsClinical Pharmacology & Therapeutics, 1975
- Imipramine-Induced Heart Block A Longitudinal Case StudyJAMA, 1975
- A Review of the Cardiovascular Effects and Toxicity of Tricyclic AntidepressantsPsychosomatic Medicine, 1975
- Assessment of Cardiovascular Side Effects of Therapeutic Doses of Tricyclic Anti‐depressant DrugsAustralian and New Zealand Journal of Medicine, 1975
- The effect of oral quinidine on intraventricular conduction in man: Correlation of plasma quinidine with changes in QRS durationAmerican Heart Journal, 1970
- AMITRIPTYLINE AND CARDIAC DISEASE: Risk of Sudden Death Identified by Monitoring SystemThe Lancet, 1970
- The hypotensive effect of imipramine hydrochloride in patients with cardiovascular diseaseClinical Pharmacology & Therapeutics, 1961